期刊文献+

装载吲哚美辛肝素类纳米胶束的制备及抗凝作用 被引量:2

Indometacin-Loaded Heparin-Based Micelles Toward Anti-thrombus
在线阅读 下载PDF
导出
摘要 肝素(hep)作为一种抗凝剂,在临床医学上广泛应用。本文以肝素为亲水段、去氧胆酸(DOCA)为疏水段合成了一种肝素类两亲性的聚合物(hep-DOCA,HD),并通过水相自组装方法,制备纳米胶束(HD-IDM),装载具有抗血栓作用的吲哚美辛(IDM),协同实现材料的抗凝血功能。通过动态光散射、Zeta电势和透射电子显微镜(TEM)等技术手段表征了纳米胶束结构和性能。当纳米胶束载药量为0.0913mg/mL时,载药纳米胶束浓度为0.4g/L,此时细胞存活率为92.81%,溶血率为0.83%,表明载药胶束具有良好的生物相容性。肝素钠,hep-DOCA和HD-IDM的全血凝血指数分别为86.48%、77.47%和89.53%,全血凝血时间分别为927、837和965s,血栓凝块实验中产生的血栓质量分别为0.11、0.20和0.07g,证明载药纳米胶束具有优良的抗凝血效果。 Heparin has been used as anti-thrombotic agents clinically.In this work,the copolymer based on hydrophilic heparin and hydrophobic deoxycholic acid(hep-DOCA,HD)was synthesized.Indometacin(IDM)-loaded HD micelles were prepared through aqueous self-assembly to enhance the anti-thrombotic capability of micelles synergistically and characterized by dynamic light scattering,Zeta potential and transmission electron microscopry(TEM).When the drug content of the nanomicelles was 0.0913 g/L,the concentration of the drug-loaded nanomicelle was 0.4 g/L,and the cell survival rate and hemolysis rate were 92.81%and 0.83%,indicating that the drug-loaded nanomicelles had good biocompatibility.The whole blood coagulation indexes of heparin sodium,hep-DOCA and HD-IDM were 86.48%,77.47%and 89.53%,respectively.The whole blood coagulation time was 927,837 and 965 s,respectively.The thrombus mass produced in the thrombus clotting experiment was 0.11,0.20 and 0.07 g,respectively,which confirmed that the drug-loaded nanomicelles had excellent anticoagulant effect.
作者 王焱明 李伟佳 钱升旭 赵巍 杨鹤 辛志荣 WANG Yanming;LI Weijia;QIAN Shengxu;ZHAO Wei;YANG He;XIN Zhirong(Chemistry and Chemical Engineering,Yantai University,Yantai,Shandong 264005,China)
出处 《应用化学》 CAS CSCD 北大核心 2019年第6期641-648,共8页 Chinese Journal of Applied Chemistry
基金 山东省自然科技基金(ZR2019MEM008)资助项目~~
关键词 肝素 去氧胆酸 纳米胶束 吲哚美辛 抗凝血 heparin deoxycholic acid micelles indomethacin anticoagulant
  • 相关文献

参考文献1

二级参考文献50

  • 1Michel V. Polymeric Biomaterials: Strategies of the Past vs. Strategies of the Future [ J ]. Progress Polymer Science, 2007, 32 (8 -9) : 755 -761.
  • 2Wemer C, Mait M F, Sperling C. Current Strategies Towards Hemocompatible Coatings [ J ]. Journal of Material Chemistry, 2007, 17 (32) : 3 376 -3 384.
  • 3Cheng H, Ynan L, Song W, et aL Biocompatible Polymer Mate- rials : Role of Protein-surface Interactions [ J ]. Progress Polymer Science, 2008, 33 (11) : 1 059 - 1 087.
  • 4Basmadjian D, Sefton M V, Baldwin S A. Coagulation on Bi- omatirals in Flowing Blood: Some Theoretical Consideration [ J]. Biomaterials, 1997, 18 (23): 1 511- 1 522.
  • 5Roach P, Farrar D, Perry C C. Surface Tailoring for Controlled Protein Adsorption: Effect of Topography at the Nanometer Scale and Chemistry [ J ]. Journal of the American Chemical Society, 2006, 128 (12) : 3 939 -3 945.
  • 6Evan A, Donald L. Mass Spectrometric Mapping of Fibrinogen Conformation at Poly ( ethylene terephthalate ) Interfaces [ J ]. Biomaterials, 2007, 28 (27) : 3 904 -3 917.
  • 7Li Z, Kim E S, Bearer E L. Arp2/3 Complex is Required for Actin Polymerization during Platelet Shape Change [ J ]. Blood, 2002, 99(12) : 4 466 -4 474.
  • 8Ruggeri Z M, Mendolicchio G L. Adhesion Mechanisms in Plate- let Function. Circulation Research, 2007, 100 (12) : 1 673 - 1 685.
  • 9Zhou R, Vogler E A. Practical Application of a Chromogenic FXIIa Assay [ J]. Biomaterials, 2006, 27 (28) : 4 840 - 4 845.
  • 10Gorbet M B, Sefton M V. Complement Inhibition Reduces Ma- terial-induced Leukocyte Activation with PEG Modified Polysty- rene Beads (Tentagel) but not Polystyrene Beads [ J]. Journal of Biomedical Materials Research A, 2005,74 (4) : 511 - 522.

共引文献9

同被引文献15

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部